Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M72.9Revenue $M--Net Margin (%)--Altman Z-Score8.1
Enterprise Value $M-19.7EPS $-4.2Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book0.810-y EBITDA Growth Rate %--Quick Ratio21.0Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio21.0Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-39.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-66.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M15.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with NVLS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVLSJulian Robertson 2015-09-30 Buy 1.13%$12.74 - $20.16
($16.43)
$ 4.72-71%New holding650,915
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVLS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


NVLS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Congleton JonPresident and CEO 2015-12-11Buy5,000$8.1-41.73view
CONWAY ROBERT EDirector 2015-12-09Buy10,000$8.1-41.73view
Flynn James E 2015-06-23Buy250,000$14-66.29view
Hawkes Bay Master Investors (C10% Owner 2015-06-22Buy17,200$14.69-67.87view
Rock Springs Capital Managemen10% Owner 2015-06-22Buy200,000$14-66.29view
Hawkes Bay Master Investors (C10% Owner 2015-06-18Buy20,400$14.47-67.38view
Jennison Global Healthcare Mas10% Owner 2015-06-17Buy26,149$14-66.29view
GOTTLIEB ANDREWVP and General Counsel 2012-04-16Sell3,488$47.37-90.04view
ARCHER TIMOTHYCOO 2012-04-12Sell110,226$47.51-90.07view
CHEN FUSEN ERNIEEVP, Semiconductor Sys. Prods. 2012-03-14Sell34,000$47.77-90.12view

Quarterly/Annual Reports about NVLS:

    News about NVLS:

    Articles On GuruFocus.com

    More From Other Websites
    What's in Store for Nivalis (NVLS) this Earnings Season? Jan 29 2016
    NIVALIS THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jan 26 2016
    Nivalis' N91115 Gets Orphan Drug Status for Cystic Fibrosis Jan 18 2016
    Nivalis Therapeutics (NVLS) Jumps: Stock Moves Up 15.5% Jan 18 2016
    NIVALIS THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 15 2016
    Nivalis Therapeutics Announces FDA Orphan Drug Designation for N91115 in Cystic Fibrosis Jan 15 2016
    Nivalis Therapeutics Announces FDA Orphan Drug Designation for N91115 in Cystic Fibrosis Jan 15 2016
    Is Park City Group, Inc. (PCYG) A Good Stock To Buy? Dec 08 2015
    Here is What Hedge Funds Think About NTELOS Holdings Corp. (NTLS) Dec 01 2015
    NIVALIS THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 01 2015
    Nivalis Therapeutics Announces First Patient Dosed in Phase 2 Study of N91115 for Treatment of... Dec 01 2015
    Nivalis Therapeutics Announces First Patient Dosed in Phase 2 Study of N91115 for Treatment of... Dec 01 2015
    Is Synthetic Biologics Inc (SYN) Going to Burn These Hedge Funds? Nov 25 2015
    Market Data on Movers and Shakers - Research on Fenix Parts, Kirin International Holding, Nivalis... Nov 23 2015
    Nivalis Therapeutics to Present at the Stifel Healthcare Conference 2015 Nov 10 2015
    NIVALIS THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report Nov 03 2015
    NIVALIS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 02 2015
    Nivalis Therapeutics Reports Third Quarter and Nine-Month Financial Results for 2015 Nov 02 2015
    Nivalis (NVLS): A Surprise in Store this Earnings Season? Oct 30 2015
    NIVALIS THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 07 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK